Report

Global Glycine Market Size study, by Grade, by End Use and Regional Forecasts 2022-2028

  • Publish Date: Oct,2022
  • Report ID: QI037
  • Page : 200
  • Report Type : PDF (Email)
Global Glycine Market is valued at approximately XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2022-2028. Glycine, also known as gly, is the simplest amino acid with a single hydrogen atom and is abundant in nature. It is a colorless transparent solid with a sweet, sugared flavor that is water soluble. Glycine is one of the building blocks of proteins and is used as an amino acid in the human body to produce proteins. According to a study conducted by the Department of Animal Husbandry and Dairying, the population of sheep, goats, and cows in India in 2019 reached 74.26 million, 148.88 million, and 145.91 million, respectively. Because of its ability to regulate all metabolic processes, glycine is increasingly used as a nutritional supplement in the animal feed sector, and the growing population of cattle is expected to boost sales in the global market. Glycine use and consumption can result in a variety of side effects, including nausea, drowsiness, vomiting, stomach upset, and diarrhea. This discourages end-users from using glycine in their products such as animal feeds, food and beverage products, dietary supplements, and others, stifling global market growth. Furthermore, the governments of several countries are emphasizing a number of initiatives to increase cattle population and breeding activities, which is expected to increase market demand for glycine.

The key regions considered for the global Glycine market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific glycine market size is expected to grow significantly due to the region's expanding medicine sector and rising meat consumption. The increased preference for low-cost generics, as well as the growing population base, will play an important role in driving the APAC glycine market growth. North America is expected dominate the market, owing to increased adoption of change in the eating habits coupled with increased metabolic syndrome and insomnia.

Major market players included in this report are:

Ajinomoto

GEO Specialty Chemicals

Yuki Gosei Kogyo

Guangrong Chemical

Showa Denko KK

Chattem Chemicals

Evonik

Paras Intermediates Private Limited

Linxi Hongtai

Shijiazhuang Donghua Jinlong Chemical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Grade:

Food Grade

Tech Grade

Pharma Grade

By End-Use:

Food & Beverage Industry

Pesticides Industry

Pharmaceuticals Industry

Feed Industry

Cosmetics Industry

Dietary Supplements Industry

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Glycine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors